Related Experiment Video
Updated: Jul 5, 2026

The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury
Published on: October 3, 2017
Interactions between cell death induced by statins and 7-ketocholesterol in rabbit aorta smooth muscle cells
W Martinet1, D M Schrijvers, J-P Timmermans
1Division of Pharmacology, Department of Pharmaceutical Sciences, University of Antwerp, Wilrijk, Belgium.
Background And Purpose:
7-Ketocholesterol, an oxysterol present in atherosclerotic lesions, induces smooth muscle cell (SMC) death, thereby destabilizing plaques. Statins protect patients from myocardial infarction, though they induce SMC apoptosis. We investigated whether statins and 7-ketocholesterol exerted additive cell death effects.
Experimental Approach:
Cultured rabbit aorta SMCs (passage 2-6) were exposed to 7-ketocholesterol with or without fluvastatin, simvastatin or pravastatin. Uptake of neutral red (NR), monolayer protein, cleavage of the pan-caspase substrate Asp-Glu-Val-Asp-rhodamine110, cell morphology (light and electron microscopy) and processing of microtubule-associated protein 1 light chain 3 (LC3, immunoblot) were determined.
Key Results:
NR uptake declined upon 18 h exposure to 25 microM 7-ketocholesterol (-41+/-3%, n=13), 100 microM fluvastatin (-59%) or 30-100 microM simvastatin (-28 to -74%). Oxysterol and high statin concentrations exerted additive effects, but lower concentrations (fluvastatin 10-30 microM, simvastatin 1-10 microM) partly reversed viability loss. 7-Ketocholesterol caused intense cytoplasmic vacuolization, processing of LC3-I to LC3-II, but little caspase activation (increase 29.5%). Fluvastatin (10-100 microM, 70-545% increase) and simvastatin (3-100 microM 43-322% increase) induced caspase activation without LC3 processing, but failed to activate caspases in 7-ketocholesterol-treated SMCs. Pravastatin up to 100 microM was always inactive.
Conclusions And Implications:
7-Ketocholesterol caused SMC death, mainly via autophagic vesicle formation with LC3 processing, whereas lipophilic statins evoked SMC apoptosis. Cell death following 7-ketocholesterol and low statin concentrations were not additive, presumably because the autophagic process interfered with statin-induced caspase activation. This further illustrates that drug effects in normal SMCs are not necessarily predictive for activities in atherosclerotic settings.
Insights
7-Ketocholesterol induces smooth muscle cell (SMC) death via autophagy, while statins induce apoptosis. Their combined effects on cell death are not additive, suggesting differing mechanisms in atherosclerotic settings.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- 7-Ketocholesterol, an oxysterol found in atherosclerotic lesions, is known to cause smooth muscle cell (SMC) death.
- Statins are cardioprotective but can induce SMC apoptosis, raising questions about their combined effects with 7-ketocholesterol.
Purpose of the Study:
- To investigate the additive effects of statins and 7-ketocholesterol on SMC death.
- To elucidate the distinct mechanisms of cell death induced by 7-ketocholesterol and statins.
Main Methods:
- Cultured rabbit aorta SMCs were treated with 7-ketocholesterol and various statins (fluvastatin, simvastatin, pravastatin).
- Cell viability was assessed using neutral red uptake.
- Caspase activation and microtubule-associated protein 1 light chain 3 (LC3) processing (an autophagy marker) were measured.
Main Results:
- 7-Ketocholesterol induced SMC death primarily through autophagy (LC3 processing).
- Lipophilic statins (fluvastatin, simvastatin) induced SMC apoptosis (caspase activation) without LC3 processing.
- At high concentrations, 7-ketocholesterol and statins showed additive cell death, but at lower statin concentrations, cell death was not additive, potentially due to autophagy interfering with caspase activation.
Conclusions:
- 7-Ketocholesterol and lipophilic statins induce SMC death via distinct pathways: autophagy and apoptosis, respectively.
- The non-additive cell death at lower statin concentrations suggests complex interactions between these pathways.
- Drug effects observed in normal SMCs may not accurately predict outcomes in the context of atherosclerosis.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology

